Domestic companies have started to deliver tangible results with their liquid biopsy technology. The early cancer diagnosis accuracy of GC Genome’s ai-CANCERCH and IMBdx’s CancerFind were found to be over 80%. EDGC's (Eone-Diagnomics Genome Center) test showed an 80% sensitivity in diagnosing colorectal cancer.

Liquid biopsy detects diseases from blood, body fluids, or urine, enabling faster and more convenient testing than standard biopsy, which involves removing the tumor directly. Liquid biopsy can be conducted even without the patient’s tissue. Extracting tissue from cancer patients becomes increasingly difficult after the development of chemoresistance. When a biopsy is first performed, tissue extr